Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
100%(1 trials)

Phase Distribution

Ph not_applicable
5
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution5 total trials
N/ANon-phased studies
5(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(1)
Other(3)

Detailed Status

unknown3
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A5 (100.0%)

Trials by Status

recruiting120%
unknown360%
completed120%

Recent Activity

1 active trials
Showing 5 of 5
completednot_applicable

Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease

NCT04060797
recruitingnot_applicable

Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease

NCT05345431
unknownnot_applicable

The MILESTONE Study

NCT04086043
unknownnot_applicable

A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain

NCT04014478
unknownnot_applicable

Endovascular Denervation in Patients With Cancer Pain

NCT03431922

Clinical Trials (5)

Showing 5 of 5 trials
NCT04060797Not Applicable

Endovascular Denervation Improves Limb Ischemia in Patients With Peripheral Artery Disease

Completed
NCT05345431Not Applicable

Endovascular Denervation for the Treatment of Patients With Peripheral Arterial Disease

Recruiting
NCT04086043Not Applicable

The MILESTONE Study

Unknown
NCT04014478Not Applicable

A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain

Unknown
NCT03431922Not Applicable

Endovascular Denervation in Patients With Cancer Pain

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5